3D Ultrasound Imaging for Breast Cancer Detection
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications, but it does exclude those receiving cancer therapy like chemotherapy or radiation.
What data supports the effectiveness of the treatment 3D Ultrasound Breast Imaging for breast cancer detection?
How does 3D ultrasound imaging differ from other breast cancer detection treatments?
3D ultrasound imaging, specifically the 3D automated breast ultrasound system (3D ABUS), is unique because it provides high-resolution images with a large field of view, addressing limitations of traditional hand-held ultrasounds. It is particularly beneficial for women with dense breast tissue, offering a non-ionizing alternative to mammography and improving detection rates when used alongside mammography.12356
What is the purpose of this trial?
This trial is testing a new ultrasound method to better diagnose breast lumps by creating clearer and more detailed images.
Research Team
Shigao Chen, PhD
Principal Investigator
Mayo Clinic
Christine Lee, MD, PhD
Principal Investigator
Mayo Clinic in Rochester
Eligibility Criteria
This trial is for adult women over 18 with a breast lesion who are scheduled for a biopsy. It's not open to those under 18, anyone with previous breast surgery or implants, those unable to consent, pregnant or breastfeeding women, or patients currently undergoing cancer treatments.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Participants undergo 3D Multimodal Ultrasound Imaging for breast mass diagnosis
Follow-up
Participants are monitored for safety and effectiveness after imaging
Treatment Details
Interventions
- 3D Ultrasound Breast Imaging
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
United States Department of Defense
Collaborator